Search Results 1131-1140 of 16277 for monoclonal antibody
... monoclonal antibody have been used to treat EE. EE likely represents another example of eosinophil-associated inflammation of epithelia at the interface ...
Have received any monoclonal antibody therapy directed at treatment of the patient's malignancy within 2 weeks prior to anticipated first dose. Have ...
Monoclonal antibodies ≤ 3 weeks;; Radiation therapy ≤ 2 weeks;; CDK 4/6 inhibitors ≤ 4 weeks;; mTOR inhibitors ≤ 4 weeks. Participating Mayo Clinic ...
Monoclonal antibodies: at least 3 half-lives of the antibody after the last dose; Radiation therapy (RT): patients must have had their last fraction of ...
Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI · Muscle pain · Needle biopsy · Night sweats · No ...
Relapsed MM refractory to at least one IMiD, PI, and anti-CD38 antibody ... Monoclonal protein, Skin changes (POEMS) syndrome. ... Prior or concomitant treatment ...
... (monoclonal gammopathy of thrombotic/thrombocytopenic significance). ... MemberThe Antibody Society. 2021 - present. FacultyDLMP Research Strategy: Mentoring ...
... monoclonal antibodies < 28 days prior to randomization. Receipt of other investigational antiviral treatments (e.g., anti-BK monoclonal antibodies) within ...
Monoclonal antibodies: > 21 days must have elapsed from the infusion of last dose of antibody and toxicity related to antibody therapy must be recovered to ...
Treatment with any monoclonal antibody within 4 weeks of screening; History or evidence of colonic mucosal dysplasia; HIV, hepatitis B, hepatitis C, or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.